search

All clinical trials

Results 4111-4120 of 470744

Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer

SBRTBorderline Resectable Pancreatic Cancer1 more

GTI-4711-201 is designed as a Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to determine the effect to OS by adding GC4711 to SBRT following chemotherapy in patients with unresectable or borderline resectable nonmetastatic

Recruiting14 enrollment criteria

Laser Assisted Sperm Selection of Viable Immotile Testicular Sperm in Azoospermic Infertile Men...

AzoospermiaIVF

This study aims to investigate the outcome of ICSI after using LAISS for selection of viable immotile testicular sperm in azoospermic infertile men. Patients will be randomly assigned to 2 groups. In (LAISS) group, viable immotile testicular sperms will be selected before ICSI using laser assisted immotile sperm selection (study group). In (HOST) group, viable immotile testicular sperms will be selected before ICSI using hypo-osmotic swelling test (control group).

Recruiting2 enrollment criteria

Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced...

Head and Neck CancerHead and Neck Squamous Cell Carcinoma

A Phase 2 Study of Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma.

Recruiting8 enrollment criteria

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric...

Advanced Gastric Adenocarcinoma

The purpose of this study is to investigate the safety and efficacy of Camrelizumab combined with paclitaxel (albumin binding type) and S-1 for first-line treatment of advanced gastric cancer, and to further explore the curative effect of PD - L1 expression in tumor tissue, EBV virus content, microsatellite instability (MSI), DNA mismatch repair (MMR), tumor mutation load (TMB), lymphocyte subgroup and cytokines.

Recruiting28 enrollment criteria

Precision Dosing of Vancomycin in Critically Ill Children

Vancomycin

The overall objective of this project is to investigate the large-scale utility of MIPD of vancomycin at point-of-care in ICU children. This evaluation includes a comparison with the more standard approach on Clinical and patient-oriented measures.

Recruiting10 enrollment criteria

Bariatric Endoscopy and NAFLD

ObesityNAFLD2 more

Find out how bariatric endocopy will influence clinical course of non alcoholic fatty liver disease.

Recruiting23 enrollment criteria

A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease

Tay-Sachs DiseaseSandhoff Disease

The AXO-GM2-001 study is an open-label, two-stage clinical trial designed to evaluate safety and dose-escalation (Stage 1) and safety and efficacy (Stage 2) of a bilateral thalamic and intracisternal/intrathecal infusion of AXO-AAV-GM2 in pediatric participants with GM2 Gangliosidosis (also known as Tay-Sachs or Sandhoff Diseases), a set of rare and fatal pediatric neurodegenerative genetic disorders caused by defects in the HEXA (leading to Tay-Sachs disease) or HEXB (leading to Sandhoff disease) genes that encode the two subunits of the β-hexosaminidase A (HexA) enzyme. AXO-AAV-GM2 is an investigational gene therapy that aims to restore HexA function by introducing a functional copy of the HEXA and HEXB genes via co-administration of two vectors utilizing the neurotropic adeno-associated virus recombinant human 8 serotype (AAVrh.8) capsid carrying the human HEXA or HEXB cDNA. The trial is expected to enroll pediatric participants with Tay-Sachs or Sandhoff Diseases, where infantile-onset participants will range from 6 months to 20 months old, and juvenile-onset participants will range from 2 years to 12 years old.

Recruiting63 enrollment criteria

Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary...

ST Elevation Myocardial InfarctionPercutaneous Coronary Intervention

The investigators evaluate the efficacy and safety of intravenous administration of nicorandil as adjuncts to reperfusion treatment in acute ST-segment elevation acute myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).

Recruiting11 enrollment criteria

Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated...

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) who have previously received treatment with at least a BTK inhibitor. The main purpose is to compare LOXO-305 to idelalisib plus rituximab or bendamustine plus rituximab. Participation could last up to four years, and possibly longer, if the disease does not progress.

Recruiting27 enrollment criteria

Personalised Against Standard High Tibial Osteotomy

Medial Knee Osteoarthritis

A study to compare the accuracy of achieving the planned correction between personalised (TOKA) high tibial osteotomy (HTO) procedure and standard generic HTO procedure.

Recruiting22 enrollment criteria
1...411412413...47075

Need Help? Contact our team!


We'll reach out to this number within 24 hrs